NEW YORK, Sep. 8 (GenomeWeb News) - IBM has announced that Japanese research laboratory Advanced Industrial Science and Technology will use the IBM BlueGene/L supercomputer to predict 3-D protein structures.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
